Back to MW MARSHALL WACE, LLP

ANVSANVS
Showing 5 of 9 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ANNOVIS BIO INC

MARSHALL WACE, LLP holds 1.8M shares of ANVS (ANNOVIS BIO INC), worth $3.4M as of 2026-Q2. The position was increased (+55.1% shares). ANVS represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$3.4M

Current Shares

1.8M

Total Value Change

+$3.2M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+55.1%
$3.4M0.0%$1.86
37
2026-Q1
Increased
1.2M
+63.6%
$2.6M0.0%$2.58
38
2025-Q4
New
725,862
-
$2.5M0.0%$3.46
36
2025-Q3
Exited
0
-100.0%
$00.0%$2.04
0
2025-Q2
New
90,907
-
$197,2680.0%$2.05
32

Other major holders of ANVS: VOLORIDGE INVESTMENT MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used